Monday, November 29, 2021

Antiviral COVID Pills Are Coming. Will There Be Enough Tests?
A different type of COVID-19 vaccine is about to roll out around the world
mRNA vaccines changed the course of the pandemic. Now, they could cure all kinds of other diseases
New Virus Variant Stokes Concern but Vaccines Still Likely to Work
US advisers debate if all adults really need COVID boosters
Will COVID boosters change who is considered 'fully vaccinated'?
EU reviewing Pfizer's COVID antiviral pill for emergency use
FDA authorizes Pfizer, Moderna boosters for all adults
The FDA authorizes COVID booster shots for all U.S. adults
Coronavirus FAQ: What is long COVID? And what is my risk of getting it?
AstraZeneca Covid antibody treatment ‘more effective than vaccines after six months’
All vaccinated adults could soon be eligible for a Pfizer or Moderna booster
Pfizer asks the F.D.A. to authorize its Covid antiviral pill.
Pfizer agrees to license generic versions of its COVID-19 pill — in some countries
Pfizer agrees to let other companies make its COVID-19 pill
New clues to the biology of long COVID are starting to emerge
Pfizer and BioNTech ask FDA to authorize COVID vaccine booster for people 18+
Pfizer says effectiveness of COVID antiviral pill is 'beyond our wildest dreams'
The U.K. approves Merck's COVID-19 antiviral pill, calling it a world first
Pfizer says its COVID-19 pill cuts disease's worst risks by 89%
Cheap antidepressant shows promise treating early COVID-19

No comments: